Merck & Co. has outperformed the S&P 500 in 2026, rising 19% year-to-date while offering a 2.61% dividend yield supported by 15 consecutive years of dividend increases.
/Server%20racks%20by%20dotshock%20via%20Shutterstock.jpg)
Supermicro announced a new partnership with Red Hat.
RBC analysts downgrade AeroVironment stock to "Sector Perform." Here’s why the firm recommends caution in playing AVAV shares at current levels.
Five Below stock extends gains as Mizuho upgrades the discount retailer to "Outperform." Here’s why the firm believes FIVE shares will rip higher from here as the year unfolds.
T-Mobile's wireless business is unlikely to be threatened by satellite firms in the foreseeable future.
Virax stock soars on a commercial supply agreement with Fosun Diagnostics. But disciplined investors are cautioned against chasing the momentum in VRAX shares.
It is a sign of the times when BlackRock, the kingpin of the ETF world, decides to offer an ETF that is a clone of the Invesco QQQ Trust (QQQ).
/Meta%20by%20creativeneko%20via%20Shutterstock.jpg)
Meta stock gains on plans of building first-ever data center in Canada. But does it warrant buying META shares at current levels?
/A%20close-up%20of%20the%20Broadcom%20logo%20on%20a%20smartphone%20by%20Timon%20via%20Adobe%20Stock.jpeg)
One analyst believes that all of the optimism around Broadcom is priced into AVGO stock.
Paramount shares sink as Arete analyst downgrades them to “Sell.” Here’s why Pierre-Marie d’Ornano turned bearish on PSKY stock.
